Highlights Addex Therapeutics Ltd

Equities

ADXN

CH0029850754

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
0.1155 ^CHF	+0.43%		-23.26%	+151.09%

Apr. 24	Top Premarket Decliners	MT
Apr. 18	Transcript : Addex Therapeutics Ltd, 2023 Earnings Call, Apr 18, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Addex Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 18	CI
Addex Therapeutics Logs Decline in FY23 Net Loss; Revenue Rises	Apr. 18	MT
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	Apr. 18	DJ
ADRs End Higher; Biophytis Climbs 30%	Apr. 09	DJ
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data	Apr. 09	MT
Top Premarket Gainers	Apr. 09	MT
ADRs Advance, Eco Wave Power Global AB Climbs 213.4%	Apr. 08	DJ
Top Premarket Gainers	Apr. 03	MT
Addex Therapeutics Announces the Launch of Neurosterix, Company Focused on Developing Allosteric Modulators for the Treatment of Underserved Neurological Disorders	Apr. 03	CI
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders	Apr. 03	DJ
Addex to Present at the Swiss Equities Baader Conference	Jan. 09	DJ
Addex Therapeutics Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Addex Therapeutics' ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients	Nov. 14	CI
Addex Therapeutics Restores Compliance with Nasdaq's Minimum Bid Price Requirement	Nov. 08	MT
Addex Therapeutics Gets Nasdaq Nod for New American Depositary Share Ratio	23-10-20	MT
Addex-led Consortium Wins EUR4 Million Grant to Develop Mild Neurocognitive Disorders Drug	23-09-20	MT
Addex Therapeutics Ltd Announces ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Second Quarter 2024	23-09-05	CI
Addex Therapeutics Announces Data Published in Brain	23-09-04	CI
Addex Therapeutics Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Addex Therapeutics Extends Partnership With Indivior on Substance Use Disorder Treatment Research	23-08-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Addex Therapeutics Ltd

Equities

ADXN

CH0029850754

Highlights

Filters